FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A - Company Plans to Initiate Phase 2b Clinical Trial in Early 2018 Cambridge, MA – November 1, 2017 – Vi - Aspen Technology - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2017-11-01 01:14:19		FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A - Company Plans to Initiate Phase 2b Clinical Trial in Early 2018 Cambridge, MA – November 1, 2017 – Vi Add to Reading List Source URL: visterrainc.com Download Document from Source Website File Size: 111,89 KB Share Document on Facebook